TX-MARY-KAY
30.8.2022 16:26:37 CEST | Business Wire | Press release
We all have a responsibility to care for the environment and the world around us. Sustainability must be a concerted effort and a global commitment. In late June, the Sustainable Future International Conference, sponsored by Mary Kay Inc., took place at the historic Martinic Palace, a UNESCO World Heritage site. Thought leaders, experts, businesses, and non-profit executives from several industries descended on the historical grounds to share, network, and educate audiences on innovative and sustainable standards to successfully implement in the fight to preserve the world’s precious resources for current and future generations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220830005153/en/
“Because of our global footprint, we know our moral imperative is to continue Mary Kay’s legacy of doing the right thing – today, tomorrow, always. We are focused on efficient manufacturing operations by reducing our environmental impact and identifying opportunities for resource improvement. We are challenging ourselves to further entrench sustainable practices in our business through product development, design, responsible sourcing, and mitigation of plastic pollution,” said Edita Szaboova, General Manager of Mary Kay Czech Republic and Slovakia. (Photo Credit: Mary Kay Inc.)
Mary Kay Inc., a long-time advocate for sustainability, preempted the event by announcing its new sustainability strategy in 2021: Enriching Lives Today for a Sustainable Tomorrow. Enriching Lives Today for a Sustainable Tomorrow was developed with the company’s key stakeholders and is aligned with the United Nations’ Sustainable Development Goals, making Mary Kay a key part of a global coalition to effect change for a better future.
The Sustainable Future International Conference was organized by Startup Disrupt, a global marketplace for startup companies that want to help a new generation of startup founders, engineers, developers, tech innovators, and others to succeed. The event focused on the topics of smart cities (infrastructure, development), electromobility (e-mobility, energy & renewable resources, economy & policy), sustainable business (environment, taxonomy, sustainable finance), and sustainable life (agrotech, food waste, fashion disrupt, smart farming).
Speakers with diverse backgrounds and experiences shared their wisdom at the Sustainable Future conference and represented various sectors such as startup founders, executives from large and small companies, ministries, associations, unions, chambers, investment groups, policymakers (European Commission), scientific and research institutes, universities, and non-profit.
“Mary Kay’s global sustainability strategy, Enriching Lives Today for a Sustainable Tomorrow, is anchored in the three dimensions of sustainable development—economic, environmental, and social,” said Edita Szaboova, General Manager of Mary Kay Czech Republic and Slovakia. “Because of our global footprint, we know our moral imperative is to continue Mary Kay’s legacy of doing the right thing – today, tomorrow, always. We are focused on efficient manufacturing operations by reducing our environmental impact and identifying opportunities for resource improvement. We are challenging ourselves to further entrench sustainable practices in our business through product development, design, responsible sourcing, and mitigation of plastic pollution.”
“There is no Planet B! We should always keep this motto in mind. Within the European Union, many companies focus on sustainable business practices. At the Sustainable Future International Conference, we showed the best of what we have achieved here in the Czech Republic and at the same time, we inspired best practices around the world. Mary Kay with its strong vision in sustainability is an emerging force to partner with,” said Patrik Juránek, Founder and CEO of Startup Disrupt.
The next summit hosted by Startup Disrupt will take place in the Czech Republic on September 13 at Clam-Gallas Palace in Prague. The summit’s theme is Diversity which will bring together more than 50 keynote speakers from a variety of Czech and global brands. Speakers and thought leaders will participate in discussion panels on a wide array of Diversity, Equity, and Inclusion (DEI) topics: Biases and Microaggression; Employment of People with Disabilities; Inclusive Design and Innovation, and Women’s Empowerment, just to name a few. Mary Kay Inc. Global Head of Sustainability and Social Impact, Virginie Naigeon-Malek will speak at the summit on the topic of women’s empowerment and gender-responsive procurement as a powerful strategy for inclusive sustainable growth.
“Globally, 1 in 3 businesses are owned by women. Yet, on average, women-owned businesses globally win less than 1% of all procurement spending by large corporations and governments,” said Virginie Naigeon-Malek. “These two stats are two sides of the same coin: the shocking reality on one slide and the tremendous opportunity ahead on the other. Effective procurement policies and practices can be used as a powerful strategy to support women entrepreneurs in our effort to build back from the economic impacts of the pandemic, and re-think business practices with a DEI mindset – to shift towards inclusive growth. This massive gap in representation brings the opportunity to advance action to support women’s businesses across the globe - a unique opportunity to not only build back better but, most importantly, to build back equal.”
ABOUT MARY KAY
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
ABOUT STARTUP DISRUPT
Startup Disrupt was founded in 2020 and is dedicated to helping business and tech disrupters to change the ‘old’ way of thinking in industries, products, and services. The idea has been built by people from global entrepreneur communities and startup enthusiasts. The purpose of Startup Disrupt is to become a startup platform designed to provide knowledge, inspiration, and connection to entrepreneurs, startup founders, technology innovators, and startup communities all over the world. For more information, visit https://www.startupdisrupt.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005153/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom